Trial intelligence / Profile preview

Propofol Dose-Response and EEG Patterns

NCT04345926Phase 4Completed

Sponsor
Universidad de Chile
Start
Aug 2018
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol in general anesthesia, sponsored by Universidad de Chile. Primary endpoint: Change in the alpha power of EEG Spectrogram at 35 minutes. Started Aug 2018; status: completed.

02

Drugs

propofol
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT04345926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04345926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call